Upexi Secures $7.4M in Registered Direct Offering at Premium, Amends Existing Warrants
UPXI is trading near its 52-week low of $0.98 (8.2% above the low).
Summary
Upexi, Inc. announced the pricing of a registered direct offering, raising $7.4 million by selling 6.3 million shares and accompanying warrants at $1.17 per unit, a premium to its current stock price. Concurrently, the company amended existing warrants, lowering their exercise price.
Key Events · Financing and Capital Events · UPXI
-
Secured $7.4 Million in Capital
Upexi, Inc. raised $7.4 million in gross proceeds through a registered direct offering of 6,337,000 shares of common stock and accompanying warrants.
-
Offering Priced at Premium to Market
The combined offering price was $1.17 per share and accompanying warrant, which is above the current stock price of $1.06, indicating institutional interest.
-
Existing Warrants Amended
Warrants issued in December 2025 for 3,289,474 shares had their exercise price reduced from $4.00 to $2.83 and their redemption trigger lowered from $8.50 to $7.00, increasing potential dilution for existing shareholders.
-
Short Lock-Up and Equity Sales Restriction
Directors and executive officers are subject to a 15-day lock-up, and the company has a 15-day restriction on new equity issuances, with exceptions for its existing At-The-Market (ATM) program.
Analysis · UPXI · Crypto Assets
This 8-K finalizes the terms and pricing of a registered direct offering, which closed on February 9, 2026, as previously indicated by a 424B5 filing. The company successfully raised $7.4 million in gross proceeds by issuing 6,337,000 shares and an equal number of accompanying warrants. Notably, the combined offering price of $1.17 per unit is at a premium to the current market price of $1.06, demonstrating institutional confidence and providing crucial capital for general corporate purposes and its Solana (SOL) maximum return strategy. However, the offering introduces substantial dilution, representing a significant portion of the company's market capitalization. Furthermore, the company amended previously issued warrants from December 2025, reducing their exercise price from $4.00 to $2.83 and the redemption trigger from $8.50 to $7.00. This amendment makes those existing warrants more favorable for the holder and increases potential future dilution for current shareholders. The offering also includes a short 15-day lock-up for insiders and a 15-day restriction on further equity sales, with exceptions for the existing at-the-market (ATM) program, suggesting ongoing capital needs. This financing follows recent disclosures of a large ATM offering and a resale registration, indicating a continuous effort to secure liquidity.
How filings like this one have moved
In the 30 days to Oct 20, 2026, 37.4% of the 952 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.87%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, UPXI was trading at $1.06 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $66.4M. The 52-week trading range was $0.98 to $22.57. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.